Successful trial results of drug to inhibit common-cancer-causing gene
Preliminary results from an ongoing Phase 1/2 human trial indicate a new drug dubbed OMO-103 can safely and effectively inhibit the function of a gene known to drive the growth of many common forms of cancer. Source of Article